GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...
As the Centers for Disease Control and Prevention (CDC) finds that only one-quarter of older adults have received their ...
The CNBC host said that he has reminded his viewers repeatedly that when the Fed is your “enemy” you should stick to ...
Zacks.com on MSN8d
GSK Meets Study Goal for Co-Administered RSV-Shingles VaccinesGSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...
East Donegal Township is considering a tax break that would benefit an expansion of the GSK vaccine packaging facility in ...
Hosted on MSN9mon
What It’s Like to Have RSV as an Older AdultAREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is the first FDA-approved RSV vaccine to help prevent lung and lower airway infection from RSV in people 60 and older. The CDC recommends ...
Arexvy has been approved in Malaysia for RSV (respiratory syncytial virus), for older adults aged 60 and above. The vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback